Torsten Christensen

1.8k citations

23 papers · 1.4k indexed · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Family Practice top 5%

Papers in

Endocrinology, Diabetes and Metabolism 21
- Diabetes Management and Research 17
- Diabetes Treatment and Management 14
- Diabetes Management and Education 11
- Growth Hormone and Insulin-like Growth Factors 2
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
Family Practice 2

Co-authors: Meryl Brod Donald M. Bushnell Elaine Brohan Robyn von Maltzahn Per Clauson Linda Gonder‐Frederick D Wild Carrie Fidler
Journals: Journal of Medical Economics (6 papers)Quality of Life Research (4 papers)Value in Health (3 papers)Diabetes Therapy (2 papers)Advances in Therapy (2 papers)
Partner nations: Denmark United States United Kingdom

In The Last Decade

Torsten Christensen

23 papers receiving 1.4k citations

Peers

Countries citing papers authored by Torsten Christensen

Since Specialization

Citations

This map shows the geographic impact of Torsten Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Christensen more than expected).

Fields of papers citing papers by Torsten Christensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Christensen. The network helps show where Torsten Christensen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Torsten Christensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Torsten Christensen Line = papers co-authored together Torsten Christensen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials Diabetes Therapy ·Jiten Vora, Torsten Christensen, Zahra Nowrozibabaei, Steve Baín	2014	76
2	Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization Value in Health ·Meryl Brod, Michael Lyng Wolden, Torsten Christensen, Donald M. Bushnell	2013	42
3	Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes Diabetes Therapy ·Jason Yeaw, Won Chan Lee, Michael Lyng Wolden, Torsten Christensen, Danielle Groleau	2012	17
4	Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being Quality of Life Research ·Meryl Brod, Jagatheeswaran Dhanapal, Michael Lyng Wolden, Torsten Christensen	2012	58
5	Cost of Self-Monitoring of Blood Glucose in the United States Among Patients on an Insulin Regimen for Diabetes Journal of Managed Care Pharmacy ·Jason Yeaw, Won Chan Lee, Mark Aagren, Torsten Christensen	2012	78
6	Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal–bolus regimen Journal of Medical Economics ·Torsten Christensen, Jens Gundgaard, Valentina Ormeño	2011	1
7	The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management Value in Health ·Meryl Brod, Torsten Christensen, Jordan R. Cochran Hodges, Donald M. Bushnell	2011	232
8	Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey Journal of Medical Economics ·Meryl Brod, Torsten Christensen, Donald M. Bushnell	2011	77
9	Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs Journal of Medical Economics ·Carrie Fidler, Torsten Christensen, Samantha Gillard	2011	193
10	Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures Quality of Life Research ·Meryl Brod, Torsten Christensen, Mette Hammer, Stefan Schlenker, Donald M. Bushnell	2011	22
11	Measuring the health status burden in hemodialysis patients using the SF-36® health survey Quality of Life Research ·Aaron Yarlas, Michelle K. White, Min Yang, Renee N. Saris-Baglama, M Rogulska, Torsten Christensen	2010	29
12	Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes Advances in Therapy ·Edith M. Heintjes, Jordan R. Cochran Hodges, Fernie J. A. Penning‐van Beest, Torsten Christensen, Ron M. C. Herings	2010	13
13	Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen Primary care diabetes ·Jens Gundgaard, Torsten Christensen, Jordan R. Cochran Hodges	2010	3
14	Real-life dosage and clinical efficacy of biphasic insulin preparations in patients with type 2 diabetes Advances in Therapy ·Walid Fakhoury, Hartmut Richter, Torsten Christensen	2010	6
15	The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden Journal of Medical Economics ·Torsten Christensen, Carrie Fidler, Anthony Bentley, Christian Djurhuus	2010	11
16	Cost-effectiveness of somatropin for the treatment of short children born small for gestational age Clinical Therapeutics ·Torsten Christensen, Andrew Buckland, Anthony Bentley, Christian Djurhuus, H. M. Quinn	2010	7
17	Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device) Health and Quality of Life Outcomes ·Meryl Brod, Mette Hammer, Torsten Christensen, Lizeth Vanessa Sierra Huertas, Donald M. Bushnell	2009	67
18	Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure Journal of Medical Economics ·Meryl Brod, Torsten Christensen, Masaaki Ayabe, Donald M. Bushnell	2009	12
19	A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education Patient Education and Counseling ·D Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson, Linda Gonder‐Frederick	2007	406
20	Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes Quality of Life Research ·Meryl Brod, Torsten Christensen, Donald M. Bushnell	2007	24

About Torsten Christensen

Torsten Christensen is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Nephrology, Emergency Medical Services and Economics and Econometrics, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (14 papers), Diabetes Management and Education (11 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Diabetes and associated disorders (2 papers), Chronic Disease Management Strategies (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Family Practice (52 citations), Genetics (382 citations), Surgery (338 citations) and Geriatrics and Gerontology (24 citations). Torsten Christensen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Meryl Brod, Donald M. Bushnell, Elaine Brohan, Robyn von Maltzahn, Per Clauson, Linda Gonder‐Frederick, D Wild, Carrie Fidler, Samantha Gillard and Michael Lyng Wolden. Their work appears in journals such as Journal of Medical Economics, Quality of Life Research, Value in Health, Diabetes Therapy and Advances in Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact